KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments: 2015-2018

Historic Preferred Dividend Payments for Teva Pharmaceutical Industries (TEVA) over the last 3 years, with Dec 2018 value amounting to $54.0 million.

  • Teva Pharmaceutical Industries' Preferred Dividend Payments fell 16.92% to $54.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $249.0 million, marking a year-over-year decrease of 4.23%. This contributed to the annual value of $249.0 million for FY2018, which is 4.23% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Preferred Dividend Payments of $54.0 million as of Q4 2018, which was down 16.92% from $65.0 million recorded in Q3 2018.
  • In the past 5 years, Teva Pharmaceutical Industries' Preferred Dividend Payments registered a high of $66,000.0 billion during Q2 2016, and its lowest value of -$195,999.7 billion during Q4 2016.
  • In the last 3 years, Teva Pharmaceutical Industries' Preferred Dividend Payments had a median value of $65.0 million in 2018 and averaged -$5,499.9 billion.
  • Its Preferred Dividend Payments has fluctuated over the past 5 years, first tumbled by 1,306,665,026.67% in 2016, then surged by 100.00% in 2017.
  • Quarterly analysis of 4 years shows Teva Pharmaceutical Industries' Preferred Dividend Payments stood at $15.0 million in 2015, then tumbled by 1,306,665,026.67% to -$195,999.7 billion in 2016, then skyrocketed by 100.00% to $65.0 million in 2017, then decreased by 16.92% to $54.0 million in 2018.
  • Its last three reported values are $54.0 million in Q4 2018, $65.0 million for Q3 2018, and $65.0 million during Q2 2018.